Terms: = Sarcomas AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
24 results:
1. Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.
Dieudonné Y; Silvestrini MA; Dossier A; Meignin V; Jouenne F; Mahévas T; Bouaziz JD; Jackson MA; Mordant P; Poirot J; Onodi F; Calvani J; Hourseau M; Evrard D; Berisha M; Perrin F; Danel C; Borie R; Galicier L; Mourah S; Bengoufa D; Oksenhendler E; Grootenboer-Mignot S; Boutboul D
Br J Haematol; 2023 Jul; 202(2):267-278. PubMed ID: 37221131
[TBL] [Abstract] [Full Text] [Related]
2. Targeting Podoplanin for the Treatment of Osteosarcoma.
Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
[TBL] [Abstract] [Full Text] [Related]
3. [Surgical and interdisciplinary treatment of gastrointestinal stromal tumors].
Schmidt T; Ghadimi M; Fuchs HF; Bruns CJ
Chirurg; 2022 Jan; 93(1):27-33. PubMed ID: 34709443
[TBL] [Abstract] [Full Text] [Related]
4. Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
Brahmi M; Lesluyes T; Dufresne A; Toulmonde M; Italiano A; Mir O; Le Cesne A; Valentin T; Chevreau C; Bonvalot S; Penel N; Coindre JM; Le Guellec S; Le Loarer F; Karanian M; Blay JY; Chibon F
ESMO Open; 2021 Feb; 6(1):100037. PubMed ID: 33524869
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
Noguchi R; Yoshimatsu Y; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):667-674. PubMed ID: 33146842
[TBL] [Abstract] [Full Text] [Related]
6. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
[TBL] [Abstract] [Full Text] [Related]
7. Down-regulation of pdgfrβ suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition.
Xing S; Wang C; Tang H; Guo J; Liu X; Yi F; Liu G; Wu X
FEBS Open Bio; 2020 Sep; 10(9):1748-1757. PubMed ID: 32580247
[TBL] [Abstract] [Full Text] [Related]
8. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
Ibrahim A; Chopra S
Arch Pathol Lab Med; 2020 May; 144(5):655-660. PubMed ID: 31169996
[TBL] [Abstract] [Full Text] [Related]
9. Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.
Madarampalli B; Watts GFM; Panipinto PM; Nguygen HN; Brenner MB; Noss EH
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1516-1524. PubMed ID: 30876808
[TBL] [Abstract] [Full Text] [Related]
10. Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety.
Liao Z; Li F; Zhang C; Zhu L; Shi Y; Zhao G; Bai X; Hassan S; Liu X; Li T; Xing P; Zhao J; Zhang J; Xing R; Teng S; Yang Y; Chen K; Yang J
Exp Mol Med; 2019 Feb; 51(3):1-11. PubMed ID: 30816108
[TBL] [Abstract] [Full Text] [Related]
11. Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.
Davis EJ; Chugh R
Drug Des Devel Ther; 2017; 11():3579-3587. PubMed ID: 29263653
[TBL] [Abstract] [Full Text] [Related]
12. Ancillary molecular analysis in the diagnosis of soft tissue tumours: reassessment of its utility at a specialist centre.
Vroobel K; Gonzalez D; Wren D; Thompson L; Swansbury J; Fisher C; Thway K
J Clin Pathol; 2016 Jun; 69(6):505-10. PubMed ID: 26584594
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.
Rubió-Casadevall J; Borràs JL; Carmona-García MC; Ameijide A; Gonzalez-Vidal A; Ortiz MR; Bosch R; Riu F; Parada D; Martí E; Miró J; Sirvent JJ; Galceran J; Marcos-Gragera R
World J Surg Oncol; 2015 Feb; 13():47. PubMed ID: 25885906
[TBL] [Abstract] [Full Text] [Related]
14. Personalized management: inoperable gastrointestinal stromal tumors.
Bae S; Desai J
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):130-4. PubMed ID: 23981520
[TBL] [Abstract] [Full Text] [Related]
15. Expression of receptor tyrosine kinases in esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Suzuki S; Yokobori T; Sakai M; Tanaka N; Inose T; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Ojima H; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Kuwano H
Oncol Rep; 2013 Jun; 29(6):2119-26. PubMed ID: 23546020
[TBL] [Abstract] [Full Text] [Related]
16. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
Lusby K; Savannah KB; Demicco EG; Zhang Y; Ghadimi MP; Young ED; Colombo C; Lam R; Dogan TE; Hornick JL; Lazar AJ; Hunt KK; Anderson ML; Creighton CJ; Lev D; Pollock RE
Ann Surg Oncol; 2013 Jul; 20(7):2364-72. PubMed ID: 23334251
[TBL] [Abstract] [Full Text] [Related]
17. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
Caram MV; Schuetze SM
J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
[TBL] [Abstract] [Full Text] [Related]
18. ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.
Ikeda AK; Judelson DR; Federman N; Glaser KB; Landaw EM; Denny CT; Sakamoto KM
Mol Cancer Ther; 2010 Mar; 9(3):653-60. PubMed ID: 20197394
[TBL] [Abstract] [Full Text] [Related]
19. Frequent deletion of CDKN2A and recurrent coamplification of KIT, pdgfrA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
[TBL] [Abstract] [Full Text] [Related]
20. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract] [Full Text] [Related]
[Next]
